Evidence map›Paper›PMID 35235033›Full record

ReviewEuropean journal of nutrition2022

Wheat amylase/trypsin inhibitors (ATIs): occurrence, function and health aspects.

Sabrina Geisslitz, Peter Weegels, Peter Shewry, Victor Zevallos, Stefania Masci, Mark Sorrells, Armando Gregorini, Mariastella Colomba, Daisy Jonkers, Xin Huang and 5 more

Open access · hybridAbstract readReview
In one paragraph

Review in European journal of nutrition, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
6.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it, 45 citations in OpenAlex.

  1. Pooled it
  2. Observational
  3. Article
  4. Review
  5. Review
  6. Multi-Transcripts and Expressions ofPlants (Basel, Switzerland) · 2025
    Article
  7. Article
  8. Review
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Review
  18. Toll-like Receptors and Celiac Disease.International journal of molecular sciences · 2022
    Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 12 institutions in 8 countries.

Sabrina GeisslitzKarlsruhe Institute of Technology (KIT), Karlsruhe, Germany. sabrina.geisslitz@kit.edu.
Peter WeegelsNetherlands and European Bakery Innovation Centre, Sonneveld Group BV, Papendrecht, and Wageningen University and Research, Wageningen, Netherlands.
Peter ShewryLaboratory of Food Chemistry, Rothamsted Research, Harpenden, UK.
Victor ZevallosNutrition and Food Research Group, Department of Applied and Health Sciences, University of Northumbria, Newcastle Upon Tyne, UK.
Stefania MasciDepartment of Agricultural and Forestry Sciences, University of Tuscia, Tuscia, Italy.
Mark SorrellsSchool of Integrative Plant Science, Plant Breeding and Genetics Section, Cornell University, Ithaca, USA.
Armando GregoriniDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Mariastella ColombaDepartment of Biomolecular Sciences, University of Urbino "Carlo Bo", Urbino, Italy.
Daisy JonkersDivision of Gastroenterology-Hepatology, Department Internal Medicine, School for Nutrition and Translational Research in Metabolism Maastricht, Maastricht University, Maastricht, Netherlands.
Xin HuangDepartment of Food and Nutrition, Faculty of Agriculture and Forestry, University of Helsinki, Helsinki, Finland.
Roberto De GiorgioDepartment of Translational Medicine, St. Anna Hospital, University of Ferrara, Ferrara, Italy.
Giacomo P CaioDepartment of Morphology, Surgery and Experimental Medicine, University of Ferrara, Ferrara, Italy.
Stefano D'AmicoInstitute for Animal Nutrition and Feed, AGES - Austrian Agency for Health and Food Safety, Vienna, Austria.
Colette LarréINRAE UR1268 BIA, Impasse Thérèse Bertrand-Fontaine, 44000, Nantes, France.
Fred BrounsDepartment of Human Biology, School for Nutrition and Translational Research in Metabolism Maastricht, Maastricht University, Maastricht, Netherlands.ORCID http://orcid.org/0000-0001-5907-8388
Maastricht University · NLUniversity of Ferrara · ITUniversity of Urbino · ITAustrian Agency for Health and Food Safety · ATCornell University · USInstitut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement · FRKarlsruhe Institute of Technology · DENorthumbria University · GBRothamsted Research · GBUniversità degli Studi della Tuscia · ITUniversity of Helsinki · FIWageningen University & Research · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Amylase/trypsin inhibitors (ATIs) are widely consumed in cereal-based foods and have been implicated in adverse reactions to wheat exposure, such as respiratory and food allergy, and intestinal responses associated with coeliac disease and non-coeliac wheat sensitivity. ATIs occur in multiple isoforms which differ in the amounts present in different types of wheat (including ancient and modern ones). Measuring ATIs and their isoforms is an analytical challenge as is their isolation for use in studies addressing their potential effects on the human body. ATI isoforms differ in their spectrum of bioactive effects in the human gastrointestinal (GI), which may include enzyme inhibition, inflammation and immune responses and of which much is not known. Similarly, although modifications during food processing (exposure to heat, moisture, salt, acid, fermentation) may affect their structure and activity as shown in vitro, it is important to relate these changes to effects that may present in the GI tract. Finally, much of our knowledge of their potential biological effects is based on studies in vitro and in animal models. Validation by human studies using processed foods as commonly consumed is warranted. We conclude that more detailed understanding of these factors may allow the effects of ATIs on human health to be better understood and when possible, to be ameliorated, for example by innovative food processing. We therefore review in short our current knowledge of these proteins, focusing on features which relate to their biological activity and identifying gaps in our knowledge and research priorities.

Indexed as

Celiac DiseaseTrypsin InhibitorsAmylasesAnimalsHumansPlant ProteinsTrypsinAmylasesPlant ProteinsTrypsinTrypsin InhibitorsAmylase/trypsin inhibitorsATIsCoeliac diseaseIntestinal symptomsNon-coeliac wheat sensitivityWheat allergy

Identifiers

PMID35235033
PMCPMC9363355
OpenAlexW4214871054

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.